Eupraxia Pharmaceuticals Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
EPRX Company Description
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with significant unmet medical needs.
EPRX Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view EPRX Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of EPRX by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by EPRX's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of EPRX in WallStreetBets Daily Discussion
EPRX News
Recent insights relating to EPRX
CNBC Recommendations
Recent picks made for EPRX stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in EPRX
Corporate Flights
Flights by private jets registered to EPRX
Our Analysis